Integral Derivatives’s AB InBev BUD Stock Holding History

Integral Derivatives’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$891K	Sell	8,100 -20,900	-72%	-$2.32M	0.02%	266
2017 Q4	$3.23M	Buy	29,000 +11,400	+65%	+$1.34M	0.06%	200
2017 Q3	$2.1M	Sell	17,600 -5,700	-24%	-$667K	0.04%	299
2017 Q2	$2.57M	Buy	23,300 +9,500	+69%	+$1.09M	0.05%	251
2017 Q1	$1.51M	Buy	13,800 +11,500	+500%	+$1.24M	0.03%	392
2016 Q4	$243K	Sell	2,300 -13,000	-85%	-$1.46M	﹤0.01%	944
2016 Q3	$2.01M	Buy	+15,300	New	+$1.93M	0.04%	265
2015 Q4	–	Sell	-30,000	Closed	-$3.19M	–	1072
2015 Q3	$3.19M	Buy	+30,000	New	+$3.48M	0.09%	193

Other funds holding BUD

SCP

Soroban Capital Partners New York $51.8B AUM 21.41% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Integral Derivatives's BUD Position: Q3 2017 in Review

Integral Derivatives sold out of AB InBev (BUD) in Q3 2017, closing a stake of 2,425 shares — an estimated $284K sold.

Integral Derivatives first reported a position in BUD in Q1 2015 and held it in 5 quarters. The position peaked at $527K in Q2 2016. 533 funds tracked by Wall St. Rank hold BUD as of Q3 2017.

Integral Derivatives reported no remaining AB InBev position as of Q3 2017 after selling out during the quarter.
Integral Derivatives sold 2,425 AB InBev shares in Q3 2017, an estimated $284K.
Integral Derivatives first reported a position in AB InBev in Q1 2015 and held it in 5 quarters.
Integral Derivatives's AB InBev position peaked at $527K in Q2 2016.
533 funds tracked by Wall St. Rank held AB InBev as of Q3 2017.

Based on Integral Derivatives's 13F filing for Q3 2017, filed 14 Nov 2017.